Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis

Background: Use of elexacaftor/tezacaftor/ivacaftor (ETI) for treatment of cystic fibrosis (CF) has resulted in unprecedented clinical improvements necessitating development of outcome measures for monitoring disease course. Intranasal micro-optical coherence tomography (μOCT) has previously helped...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Kadambari Vijaykumar, Hui Min Leung, Amilcar Barrios, Justin Wade, Heather Y. Hathorne, David P. Nichols, Guillermo J. Tearney, Steven M. Rowe, George M. Solomon
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2024-04-01
Colecção:	Heliyon
Assuntos:	Cystic fibrosis Highly effective modulator therapies Micro-optical coherence tomography Mucociliary abnormalities
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2405844024052198
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!